Back to Search
JILL AHLERS, DMD
DMD
Dentist
NPI: 1568620730Individual
Specialties, Licenses & Credentials
General Practice Dentistry
Dentist — General Practice
Code: 1223G0001X
2287(MT)
DentistPrimary
Dentist
Code: 122300000X
61125(KS)
Research & Publications (20)
Strategies for optimizing targeting and delivery of mucosal HIV vaccines.
PMID 19609978·Eur J Immunol·2009
6-review
Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
PMID 19487159·Trends Mol Med·2009
6-review
Comment on "trafficking of antigen-specific CD8+ T lymphocytes to mucosal surfaces following intramuscular vaccination".
PMID 19201827·J Immunol·2009
7-preclinical
[Treatment options for cartilage damage in the knee joint (II)].
PMID 19119779·Versicherungsmedizin·2008
7-preclinical
Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
PMID 18838298·Trends Immunol·2008
6-review
Integrated testing and intelligent assessment-new challenges under REACH.
PMID 18818964·Environ Sci Pollut Res Int·2008
7-preclinical
[Treatment options for cartilage damage in the knee joint].
PMID 18807341·Versicherungsmedizin·2008
6-review
Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.
PMID 18793787·Virology·2008
7-preclinical
Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs.
PMID 17981793·Int Immunol·2007
7-preclinical
Acute to chronic ratios in aquatic toxicity--variation across trophic levels and relationship with chemical structure.
PMID 17089717·Environ Toxicol Chem·2006
7-preclinical
Progress on new vaccine strategies against chronic viral infections.
PMID 15314679·J Clin Invest·2004
6-review
Mucosal AIDS vaccines: current status and future directions.
PMID 15285706·Expert Rev Vaccines·2004
6-review
Progress on new vaccine strategies for the immunotherapy and prevention of cancer.
PMID 15173875·J Clin Invest·2004
6-review
Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells.
PMID 15057306·J Clin Invest·2004
7-preclinical
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.
PMID 12869693·Proc Natl Acad Sci U S A·2003
7-preclinical
Environmental risk assessment of airborne trichloroacetic acid--a contribution to the discussion on the significance of anthropogenic and natural sources.
PMID 12738278·Chemosphere·2003
8-other
Cytokine, chemokine, and costimulatory molecule modulation to enhance efficacy of HIV vaccines.
PMID 12699364·Curr Mol Med·2003
6-review
Selective induction of high avidity CTL by altering the balance of signals from APC.
PMID 12594278·J Immunol·2003
7-preclinical
A push-pull approach to maximize vaccine efficacy: abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L.
PMID 12232042·Proc Natl Acad Sci U S A·2002
7-preclinical
Assessing CD4+ helper T-lymphocyte responses by lymphoproliferation.
PMID 12125133·Methods Mol Med·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 89 ALPINE RIDGE LN
BENNINGTON, KS 67422 - Phone
- (406) 422-9766
Quick Facts
- NPI
- 1568620730
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile